cGxP.wire https://validator.w3.org/feed/docs/rss2.html Servier Acquires Edgewise Muscular Dystrophy Business for $2.65B AbbVie Secures EU Approval for AQUIPTA as Acute Migraine Treatment Evogene Reports Positive Phase 1 Data for BMC128 in Cancer Resmed Completes Noctrix Health Acquisition to Expand Sleep Care SCIEX Launches AI-Powered Novus V55 Mass Spectrometry System Fulcrum Ends Pociredir Program After FDA Concerns Over Sickle Cell Therapy Galmed and Tissue Dynamics Uncover Novel Pathway in Cardiac Fibrosis Telix and United Imaging Partner to Advance AI-Driven Theranostics Abivax’s Obefazimod Delivers Landmark Phase 3 Success in Ulcerative Colitis ImmunityBio Highlights ANKTIVA Data in Lung and Bladder Cancer at ASCO 2026 SCIEX Expands ZenoTOF Platform with AI and Omics Research Innovations Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Technology Telix Presents Encouraging Phase 3 Results for TLX591-Tx at ASCO 2026 Ansun Biopharma Advances Phase 3 DAS181 Trial Following Positive DMC Review Convergent’s CONV01-α Shows Promising Activity in Post-Lu-PSMA Prostate Cancer Phase 2 Study Cirius Therapeutics Highlights CIR-0602K as Promising New Therapy for Type 2 Diabetes Karyopharm Highlights Phase 3 SENTRY Trial Progress in Myelofibrosis Made Scientific Selected for Columbia’s NOVAKnee Program Ono’s ONO-4578 Improves Progression-Free Survival in Gastric Cancer Phase 2 Study Endeavor Health Unveils Advanced Genetic Test for Heart Disease Roche’s Giredestrant NDA Accepted by FDA for Early Breast Cancer Paradigm Health Advances Oncology Research with SPIRE-Powered ASCO Study FDA Accepts Genentech NDA for Giredestrant in Early Breast Cancer Greywolf Reports Durable Responses with First-in-Class ERAP1 Inhibitor Hummingbird Diagnostics Unveils Lung Cancer Liquid Biopsy Biomarker Mechanism Iterion Reports First Clinical Validation of Tegavivint in Advanced HCC UCB and Biogen Report Positive Phase 3 Lupus Results for Dapirolizumab Pegol in The Lancet Rallybio and Avenzo Merge to Advance Oncology Pipeline with $215M Financing Vertex FDA Accepts Povetacicept BLA for IgA Nephropathy Agilent and Sound Analytics Advance Drug Metabolism LC/MS Avenzo Reports Promising Phase 1 Data for AVZO-021 in HR+ Breast Cancer SystImmune’s BL-M14D1 Shows Strong Activity in SCLC Protagonist to Showcase Phase 3 VERIFY and Long-Term Rusfertide Data at EHA 2026 Citius Oncology Reports Promising LYMPHIR Cancer Data Servier’s Emi-Le Shows Promise in Rare ACC Cancer Trial IDEAYA and Servier Report Breakthrough mUM Phase 3 Data Amgen’s IMDYLLTRA Wins EU Approval for Small Cell Lung Cancer PCA SKIN Launches Triple Exfoliation Peel Pads for Home Use NeuroPace Wins FDA Approval for AI-Powered Epilepsy Tool Foundation Medicine Gains FDA Approval for TALZENNA CDx Haisco and Lilly Forge $3B Deal to Advance New Medicines Novartis Highlights Immunology Pipeline Progress at EULAR 2026 Curium Invests €32M to Expand Prostate Cancer RLT Production Wockhardt’s ZAYNICH Wins FDA Approval for Drug-Resistant cUTIs Bristol Myers Squibb Camzyos Gains FDA Priority Review Agios Expands Rare Hematology Portfolio with Global Cevidoplenib Licensing Deal Revolution Medicines Daraxonrasib Doubles Survival in PDAC ITM Highlights Phase 3 COMPETE Data Supporting Simplified Dosimetry for ITM-11 in GEP-NETs BioInvent to Showcase BI-1206 and BI-1808 Hematology Progress at June KOL Event Senzime Launches New Sustainable TetraSens EMG Sensor